Cited by 34Myasthenia Gravis and ThymomaAutoimmune Neurological Disorders and TreatmentsPeripheral Neuropathies and Disorders

Antibody-mediated impairment and homeostatic plasticity of autonomic ganglionic synaptic transmission

Open access
Wang, Zhengbei, Low, Phillip A., Vernino, Steven·2010·Experimental Neurology

Abstract

Antibodies against ganglionic acetylcholine receptors (AChR) are implicated as the cause of autoimmune autonomic ganglionopathy (AAG). To characterize ganglionic neurotransmission in an animal model of AAG, evoked and spontaneous excitatory post-synaptic potentials (EPSP) were recorded from neurons in isolated mouse superior cervical ganglia (SCG). In vitro exposure of ganglia to IgG from AAG patients progressively inhibited synaptic transmission. After passive transfer of antibody to mice, evoked EPSP amplitude decreased, and some neurons showed no synaptic responses. EPSP amplitude recovered by day 7 despite persistence of ganglionic AChR antibody in the mouse serum. There was a more persistent (at least 14-day) reduction in miniature EPSP amplitude consistent with antibody-mediated reduction in post-synaptic AChR. Although the quantal size was reduced, a progressive increase in the frequency of spontaneous synaptic events occurred, suggesting a compensatory increase in presynaptic efficacy. The quantal size returned to baseline by 21 days while the frequency remained increased for at least four weeks. Ganglionic AChR antibodies cause an impairment of autonomic ganglionic synaptic transmission. Homeostatic plasticity in autonomic neurotransmission could help explain the spontaneous clinical recovery seen in some AAG patients and may also play an important role in regulating normal autonomic reflexes.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.expneurol.2009.12.016

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Anti-gAChR antibodies may impair autonomic ganglionic synaptic transmission, and antibodies that interfere with ganglionic transmission may contribute to dysautonomia in patients with POTS.

    “Anti-gAChR antibodies may impair autonomic ganglionic synaptic transmission, and antibodies that interfere with ganglionic transmission may contribute to dysautonomia in patients with POTS.18”

    From Autoimmune postural orthostatic tachycardia syndrome (2018) · cites this paper as [18]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

  • Autoimmune postural orthostatic tachycardia syndrome

    Watari, M., Nakane, S., Mukaino, A., Nakajima, M., Mori, Y., Maeda, Y., Masuda, T., Takamatsu, K., Kouzaki, Y., Higuchi, O., et al. (2018) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.524 · Cited by 94 · see citing works

    “The prevalence of anti-gAChR antibodies in this study was higher than that in previous study.17 Anti-gAChR antibodies may impair autonomic ganglionic synaptic transmission, and antibodies that interfere with ganglionic transmission may contribute to dysautonomia in patients with POTS.18 Although POTS is pathophysiolog…”
    BackgroundInfluential

Authors
Wang, Z., Low, P. A., & Vernino, S.
Affiliations
  • The University of Texas Southwestern Medical Center (US)
  • Mayo Clinic (US)
Corresponding author
Vernino, Steven
Venue
Experimental Neurology
Publisher
Elsevier BV
Published
2010-03
Volume
222
Issue
1
Pages
114-119
ISSN
0014-4886 (ISSN-L)
OpenAlex
W2024843700
Cited by
34
References
24
Citations by year
2026: 2 · 2024: 1 · 2023: 2 · 2022: 2 · 2021: 3 · 2020: 4 · 2019: 1 · 2018: 3 · 2017: 2 · 2016: 3 · 2015: 2 · 2013: 3
FWCI
1.53
Type
journal article
Language
en
Open access
Locations
  • Experimental Neurology (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • Johns Hopkins University
  • University of Texas Southwestern Medical Center
  • National Institutes of Health
  • National Institute of Neurological Disorders and Stroke (P50NS 32352, P50NS032352)
Topics
  • Health Sciences › Medicine › Neurology › Myasthenia Gravis and Thymoma
  • Health Sciences › Medicine › Neurology › Autoimmune Neurological Disorders and Treatments
  • Health Sciences › Medicine › Neurology › Peripheral Neuropathies and Disorders
Keywords
autoimmune autonomic ganglionopathy, acetylcholine receptor antibodies, superior cervical ganglion, synaptic transmission, homeostatic plasticity, excitatory postsynaptic potentials, quantal size, passive antibody transfer, autonomic reflexes
MeSH terms
Adult, Animals, Autonomic Nervous System Diseases, Electric Stimulation, Female, Ganglia, Autonomic, Humans, Immunoglobulin G, Male, Mice, Inbred C57BL, Middle Aged, Neuronal Plasticity, Neurons, Receptors, Nicotinic, Time Factors, Microscopy, Immunoelectron, Superior Cervical Ganglion, Excitatory Postsynaptic Potentials, Mice, Young Adult, In Vitro Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review